US · Healthcare · Health Information Services
EPS came in at 0.21 against a street estimate of 0.21 — a beat of 0.0%.
Analysts rate NRC Health a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $27.00.
| Fund | Stake |
|---|---|
| Kayne Anderson Rudnick Investment Management LLC | 9.18% |
| BlackRock Inc | 4.80% |
| Morgan Stanley - Brokerage Accounts | 3.88% |
| Vanguard Capital Management, LLC | 3.01% |
| Dimensional Fund Advisors, Inc. | 2.22% |
| Willis Investment Counsel | 1.97% |
| Geode Capital Management, LLC | 1.90% |
| QV Investors Inc | 1.68% |
| Action | Detail | Date |
|---|---|---|
| Dividend | $0.16 / share ex-date Sep 25, 2026 · pay Oct 9, 2026 | 2026-09-25 |
| Dividend | $0.16 / share ex-date Jun 26, 2026 · pay Jul 10, 2026 | 2026-06-26 |
| Dividend | $0.16 / share ex-date Mar 27, 2026 · pay Apr 10, 2026 | 2026-03-27 |
| Dividend | $0.16 / share ex-date Dec 26, 2025 · pay Jan 9, 2026 | 2025-12-26 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for NRC Health — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.